Tracking DERM? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Journey Medical Corporation (DERM) short interest & options flow

NASDAQ

Journey Medical Corporation just reported Q1 2026 results that landed modestly ahead of revenue estimates — $15.96M versus the $15.95M consensus — with EPS of -$0.08, in line with expectations. Management signalled positive EBITDA for the rest of 2026 and plans to add up to five new sales professionals. On paper, a constructive print. Yet the stock closed Tuesday at $5.01, down 3.3%…

Latest pulse13 May 2026

DERM short interest utilization hits 90.32%, near 52-week high of 99.63%.

$5.17+4.13% 1d-12.52% 1w-29.27% 1mClose: 19 Oct 2026

Short interest % of float: High
Cost to borrow
Availability: Low
Put / call ratio

Market cap: $146M
Next earnings: 10 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 20 Oct 2026

Latest signals on DERM

Utilization13 May 2026
DERM short interest utilization hits 90.32%, near 52-week high of 99.63%.

DERM news and analysis

RSS

No long-form analysis yet for DERM. Pulse alerts and the live data picture are available on ORTEX.

Open DERM on ORTEX →

Want the live picture for DERM?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DERM — free to start on ORTEX.